NASDAQ : HOWL
Werewolf Therapeutics, Inc. — Financial statements
Healthcare · Biotechnology · United States
Last price 0.9861 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 47.92M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Werewolf Therapeutics, Inc. (HOWL) reported revenue of 21.00M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Revenue | 21.00M | 1.89M | 19.94M | 16.40M | ||
| Cost of Revenue | 26.18M | 41.73M | 53.09M | 38.91M | 50.96M | 33.98M |
| Gross Profit | -5.18M | -41.73M | -51.20M | -18.96M | -34.55M | -33.98M |
| Selling, General & Admin | 20.39M | 18.95M | 22.39M | 21.54M | 21.50M | 16.11M |
| Operating Expenses | 20.39M | 18.95M | 22.39M | 21.54M | 21.50M | 16.11M |
| Operating Income | -25.57M | -60.68M | -73.59M | -40.50M | -56.06M | -50.09M |
| Interest Expense | -4.55M | -5.27M | -4.66M | -3.14M | ||
| Interest & Investment Income | 1.97M | 3.11M | 6.67M | 7.42M | 1.91M | 104.00K |
| Other Non Operating Income (Expenses) | 2.58M | 2.02M | 1.61M | -1.14M | 338.00K | |
| EBT Excluding Unusual Items | -25.57M | -60.82M | -69.96M | -37.37M | -53.81M | -49.98M |
| Other Unusual Items | -3.35M | -553.00K | ||||
| Pretax Income | -34.61M | -60.82M | -70.52M | -37.37M | -53.81M | -49.98M |
| Net Income | -34.61M | -60.82M | -70.52M | -37.37M | -53.81M | -49.98M |
| Preferred Dividends & Other Adjustments | 151.94M | |||||
| Net Income to Common | -34.61M | -60.82M | -70.52M | -37.37M | -53.81M | -201.93M |
| Shares Outstanding (Basic) | 47.87M | 46.02M | 43.33M | 35.65M | 28.86M | 18.45M |
| Shares Outstanding (Diluted) | 47.87M | 46.81M | 43.86M | 35.65M | 28.86M | 18.45M |
| EPS (Basic) | -0.72 | -1.32 | -1.63 | -1.05 | -1.86 | -10.94 |
| EPS (Diluted) | -0.75 | -1.33 | -1.63 | -1.05 | -1.86 | -10.94 |
| Free Cash Flow | -30.15M | -60.29M | -56.44M | -33.38M | -44.21M | -43.37M |
| Free Cash Flow Per Share | -0.63 | -1.29 | -1.29 | -0.94 | -1.53 | -2.35 |
| Gross Margin | -24.69% | -95.09% | -210.69% | |||
| Operating Margin | -121.78% | -3,904.19% | -203.09% | -341.78% | ||
| Profit Margin | -164.82% | -3,740.85% | -187.37% | -328.09% | ||
| Free Cash Flow Margin | -143.56% | -2,994.27% | -167.38% | -269.54% | ||
| EBITDA | -21.92M | -59.04M | -71.78M | -38.74M | -54.95M | -49.87M |
| EBITDA Margin | -104.39% | -194.25% | ||||
| D&A For EBITDA | 3.65M | 1.63M | 1.81M | 1.76M | 1.10M | 216.00K |
| EBIT | -25.57M | -60.68M | -73.59M | -40.50M | -56.06M | -50.09M |
| EBIT Margin | -121.78% | -203.09% |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 21.99M | 57.05M | 111.00M | 134.34M | 129.31M | 157.53M |
| Cash & Short-Term Investments | 21.99M | 57.05M | 111.00M | 134.34M | 129.31M | 157.53M |
| Accounts Receivable | 400.00K | 4.10M | ||||
| Other Receivables | 950.00K | 2.83M | ||||
| Receivables | 1.35M | 6.93M | ||||
| Prepaid Expenses | 905.00K | 1.54M | 2.07M | 2.47M | 3.96M | 3.44M |
| Restricted Cash | 211.00K | 100.00K | ||||
| Total Current Assets | 22.89M | 58.59M | 113.07M | 138.37M | 140.20M | 161.07M |
| Property, Plant & Equipment | 1.26M | 9.90M | 12.32M | 14.85M | 17.45M | 16.32M |
| Other Long-Term Assets | 906.00K | 1.54M | 21.62M | 2.59M | 1.86M | |
| Total Assets | 24.16M | 69.40M | 126.93M | 174.83M | 160.25M | 179.25M |
| Accounts Payable | 1.94M | 754.00K | 3.04M | 1.34M | 1.22M | 2.04M |
| Accrued Expenses | 5.81M | 5.26M | 10.23M | 8.41M | 13.41M | 8.60M |
| Current Portion of Long-Term Debt | 28.24M | 6.67M | ||||
| Current Portion of Leases | 1.75M | 1.56M | 1.61M | 2.08M | 1.07M | |
| Current Unearned Revenue | 907.00K | 6.53M | ||||
| Other Current Liabilities | 118.00K | 147.00K | 356.00K | 447.00K | 740.00K | 163.00K |
| Total Current Liabilities | 7.86M | 36.15M | 15.18M | 19.38M | 23.99M | 11.87M |
| Long-Term Debt | 26.09M | 32.66M | ||||
| Long-Term Leases | 7.68M | 9.44M | 10.99M | 12.60M | 14.59M | |
| Long-Term Unearned Revenue | 433.00K | 1.13M | ||||
| Other Long-Term Liabilities | 759.00K | 2.83M | 191.00K | |||
| Total Liabilities | 7.86M | 44.59M | 53.54M | 63.46M | 37.91M | 26.46M |
| Common Stock | 5.00K | 5.00K | 5.00K | 4.00K | 3.00K | 2.00K |
| Additional Paid-In Capital | 501.56M | 500.21M | 487.97M | 455.44M | 429.04M | 405.68M |
| Retained Earnings | -485.27M | -475.41M | -414.59M | -344.07M | -306.70M | -252.90M |
| Total Common Equity | 16.29M | 24.80M | 73.39M | 111.37M | 122.34M | 152.79M |
| Shareholders' Equity | 16.29M | 24.80M | 73.39M | 111.37M | 122.34M | 152.79M |
| Total Liabilities & Equity | 24.16M | 69.40M | 126.93M | 174.83M | 160.25M | 179.25M |
| Total Debt | 37.67M | 37.09M | 51.92M | 14.68M | 15.66M | |
| Net Cash (Debt) | 21.99M | 19.38M | 73.91M | 82.42M | 114.63M | 141.87M |
| Net Cash Per Share | 0.46 | 0.41 | 1.69 | 2.31 | 3.97 | 7.69 |
| Filing Date Shares Outstanding | 48.60M | 48.60M | 44.83M | 42.74M | 35.28M | 27.65M |
| Total Common Shares Outstanding | 48.60M | 48.60M | 44.83M | 39.11M | 31.52M | 27.61M |
| Working Capital | 15.03M | 22.44M | 97.89M | 118.99M | 116.21M | 149.19M |
| Book Value Per Share | 0.34 | 0.51 | 1.64 | 2.85 | 3.88 | 5.53 |
| Tangible Book Value | 16.29M | 24.80M | 73.39M | 111.37M | 122.34M | 152.79M |
| Tangible Book Value Per Share | 0.34 | 0.51 | 1.64 | 2.85 | 3.88 | 5.53 |
| Machinery | 3.33M | 3.33M | 3.16M | 2.32M | 1.07M | |
| Construction In Progress | 106.00K | 1.96M | ||||
| Leasehold Improvements | 7.97M | 7.97M | 7.97M | 7.97M | 274.00K |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -34.61M | -60.82M | -70.52M | -37.37M | -53.81M | -49.98M |
| Depreciation & Amortization | 3.65M | 1.63M | 1.81M | 1.76M | 1.10M | 216.00K |
| Other Amortization | 60.00K | 203.00K | ||||
| Loss (Gain) From Sale of Assets | 159.00K | 7.00K | ||||
| Stock-Based Compensation | 3.79M | 6.25M | 8.83M | 8.01M | 7.40M | 4.09M |
| Other Operating Activities | 2.24M | 856.00K | 1.16M | 818.00K | 1.96M | 519.00K |
| Change in Accounts Receivable | 1.35M | 5.58M | -6.93M | |||
| Change in Accounts Payable | -3.45M | -7.50M | 3.46M | -4.33M | 3.05M | 1.01M |
| Change in Unearned Revenue | -1.34M | -6.32M | 7.66M | |||
| Change in Other Net Operating Assets | -1.93M | -707.00K | -939.00K | -817.00K | -1.24M | 1.27M |
| Operating Cash Flow | -30.15M | -60.29M | -56.19M | -32.61M | -40.60M | -42.88M |
| Capital Expenditures | -254.00K | -769.00K | -3.61M | -498.00K | ||
| Investing Cash Flow | 416.00K | -254.00K | -769.00K | -3.61M | -498.00K | |
| Long-Term Debt Issued | 30.00M | 40.00M | ||||
| Long-Term Debt Repaid | -40.00M | |||||
| Net Debt Issued (Repaid) | -32.41M | -10.00M | 40.00M | |||
| Issuance of Common Stock | 5.64M | 6.03M | 23.75M | 18.43M | 15.99M | 111.81M |
| Other Financing Activities | -673.00K | -88.00K | -2.38M | |||
| Financing Cash Flow | -26.77M | 6.03M | 13.08M | 58.43M | 15.91M | 109.43M |
| Net Cash Flow | -56.50M | -54.26M | -43.36M | 25.05M | -28.30M | 66.05M |
| Free Cash Flow | -30.15M | -60.29M | -56.44M | -33.38M | -44.21M | -43.37M |
| Free Cash Flow Margin | -143.56% | -2,994.27% | -167.38% | -269.54% | ||
| Free Cash Flow Per Share | -0.63 | -1.29 | -1.29 | -0.94 | -1.53 | -2.35 |
| Levered Free Cash Flow | -12.23M | -40.27M | -34.04M | -22.16M | -26.18M | -24.49M |
| Unlevered Free Cash Flow | -9.39M | -36.97M | -31.13M | -20.26M | -26.39M | -24.49M |
| Cash Interest Paid | 2.91M | 3.13M | 3.36M | 2.56M | ||
| Change in Working Capital | -5.38M | -8.21M | 2.53M | -5.89M | 2.54M | 2.28M |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 48.60M | 30.75M | 65.95M | 139.70M | 63.03M | 328.47M |
| Enterprise Value | 26.61M | 2.34M | -20.10M | 61.83M | -62.26M | 160.07M |
| Last Close Price | 0.99 | 0.63 | 1.48 | 3.86 | 2.05 | 11.91 |
| PS Ratio | 2.34 | 34.99 | 7.00 | 3.84 | ||
| PB Ratio | 2.94 | 1.24 | 0.90 | 1.25 | 0.52 | 2.15 |
| P/TBV Ratio | 3.01 | 1.24 | 0.90 | 1.25 | 0.52 | 2.15 |
| EV/Sales Ratio | 1.29 | 3.10 | ||||
| Debt / Equity Ratio | 1.52 | 0.51 | 0.47 | 0.12 | 0.10 | |
| Net Debt / Equity Ratio | -1.35 | -0.78 | -1.01 | -0.74 | -0.94 | -0.93 |
| Net Debt / EBITDA Ratio | 1.00 | 0.33 | 1.03 | 2.13 | 2.09 | 2.85 |
| Net Debt / FCF Ratio | 0.73 | 0.32 | 1.31 | 2.47 | 2.59 | 3.27 |
| Asset Turnover | 0.36 | 0.01 | 0.12 | 0.10 | ||
| Quick Ratio | 2.80 | 1.58 | 7.31 | 7.00 | 5.68 | 13.27 |
| Current Ratio | 2.91 | 1.62 | 7.45 | 7.14 | 5.84 | 13.56 |
| Return on Equity (ROE) | -119.86% | -123.88% | -76.33% | -31.98% | -39.12% | -41.31% |
| Return on Assets (ROA) | -27.39% | -38.63% | -30.48% | -15.11% | -20.64% | -22.71% |
| Return on Capital Employed (ROCE) | -157.00% | -182.50% | -65.90% | -26.10% | -41.10% | -29.90% |
| Earnings Yield | -75.02% | -197.79% | -106.92% | -26.75% | -85.38% | -15.22% |
| FCF Yield | -61.42% | -196.07% | -85.58% | -23.89% | -70.14% | -13.21% |
| Buyback Yield / Dilution | -7.56% | -6.73% | -23.04% | -23.50% | -56.40% | -1,736.32% |